A038290 Stock Overview
Provides precision medicine and bio-engineering healthcare services in Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Macrogen, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,420.00 |
| 52 Week High | ₩26,700.00 |
| 52 Week Low | ₩14,700.00 |
| Beta | -0.13 |
| 1 Month Change | 0.18% |
| 3 Month Change | -8.32% |
| 1 Year Change | -19.90% |
| 3 Year Change | -42.28% |
| 5 Year Change | -32.84% |
| Change since IPO | -25.59% |
Recent News & Updates
Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13
Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Recent updates
Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Macrogen's (KOSDAQ:038290) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 02Macrogen (KOSDAQ:038290) Has Debt But No Earnings; Should You Worry?
Mar 03Reflecting on Macrogen's (KOSDAQ:038290) Share Price Returns Over The Last Three Years
Jan 09
Shareholder Returns
| A038290 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -1.3% | -0.9% | -1.6% |
| 1Y | -19.9% | 36.8% | -9.1% |
Return vs Industry: A038290 underperformed the KR Life Sciences industry which returned 36.8% over the past year.
Return vs Market: A038290 underperformed the KR Market which returned -9.1% over the past year.
Price Volatility
| A038290 volatility | |
|---|---|
| A038290 Average Weekly Movement | 5.2% |
| Life Sciences Industry Average Movement | 8.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A038290 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A038290's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 519 | Changhoon Kim | www.macrogen.com |
Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In Situ/spatial) services. The company also provides whole genome, whole exome, transcriptome, epigenome, and metagenome sequencing services; standard sequencing, identification, fragment, customized sequencing, and human ID services; expression, genome, and epigenome microarray; proteomics olink; gene synthesis; DNA and RNA oligo synthesis, and peptide synthesis; and CRISPR knock-in/out, GEM, and mass production services.
Macrogen, Inc. Fundamentals Summary
| A038290 fundamental statistics | |
|---|---|
| Market cap | ₩165.15b |
| Earnings (TTM) | -₩21.73b |
| Revenue (TTM) | ₩131.73b |
1.2x
P/S Ratio-7.5x
P/E RatioIs A038290 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A038290 income statement (TTM) | |
|---|---|
| Revenue | ₩131.73b |
| Cost of Revenue | ₩80.15b |
| Gross Profit | ₩51.58b |
| Other Expenses | ₩73.31b |
| Earnings | -₩21.73b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.18k |
| Gross Margin | 39.16% |
| Net Profit Margin | -16.50% |
| Debt/Equity Ratio | 40.8% |
How did A038290 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield-14%
Payout RatioDoes A038290 pay a reliable dividends?
See A038290 dividend history and benchmarks| Macrogen dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 25 2025 |
| Days until Ex dividend | 6 days |
| Days until Dividend pay date | 125 days |
Does A038290 pay a reliable dividends?
See A038290 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 16:21 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Macrogen, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Song-hyup Han | Daishin Securities Co. Ltd. |
| Sang-Hun Lee | iM Securities |
| Jaehoon Choi | Korea Investment & Securities Co., Ltd. |